Amneal Scores Second US Biosimilar Approval With Avastin Rival
Alymsys Bevacizumab With mAbxience Is Second Of Three Expected Nods This Year
• By David Wallace
Amneal now has two biosimilar approvals and is lining up a third • Source: amana images inc. / Alamy Stock Photo 
